<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell Mol Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell. Mol. Neurobiol</journal-id>
<journal-title-group>
<journal-title>Cellular and Molecular Neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0272-4340</issn>
<issn pub-type="epub">1573-6830</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29802603</article-id>
<article-id pub-id-type="pmc">6061125</article-id>
<article-id pub-id-type="publisher-id">589</article-id>
<article-id pub-id-type="doi">10.1007/s10571-018-0589-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8146-0740</contrib-id>
<name>
<surname>Stefano</surname>
<given-names>G. B.</given-names>
</name>
<address>
<email>gbstefano@yahoo.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pilonis</surname>
<given-names>N.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ptacek</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raboch</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vnukova</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kream</surname>
<given-names>R. M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label>Department of Psychiatry, First Faculty of Medicine Charles University in Prague and General University Hospital in Prague, Center for Cognitive and Molecular Neuroscience, Ke Karlovu 11, 120 00 Prague 2, Czech Republic </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000113287408</institution-id><institution-id institution-id-type="GRID">grid.13339.3b</institution-id><institution>Warsaw Medical University, Public Central Teaching Hospital, </institution></institution-wrap>Warsaw, Poland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>25</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>25</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>38</volume>
<issue>6</issue>
<fpage>1197</fpage>
<lpage>1206</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>It has become apparent that the molecular and biochemical integrity of interactive families, genera, and species of human gut microflora is critically linked to maintaining complex metabolic and behavioral processes mediated by peripheral organ systems and central nervous system neuronal groupings. Relatively recent studies have established intrinsic ratios of enterotypes contained within the human microbiome across demographic subpopulations and have empirically linked significant alterations in the expression of bacterial enterotypes with the initiation and persistence of several major metabolic and psychiatric disorders. Accordingly, the goal of our review is to highlight potential thematic/functional linkages of pathophysiological alterations in gut microbiota and bidirectional gut–brain signaling pathways with special emphasis on the potential roles of gut dysbiosis on the pathophysiology of psychiatric illnesses. We provide critical discussion of putative thematic linkages of Parkinson’s disease (PD) data sets to similar pathophysiological events as potential causative factors in the development and persistence of diverse psychiatric illnesses. Finally, we include a concise review of preclinical paradigms that involve immunologically–induced GI deficits and dysbiosis of maternal microflora that are functionally linked to impaired neurodevelopmental processes leading to affective behavioral syndromes in the offspring.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Microbiome</kwd>
<kwd>Psychiatry</kwd>
<kwd>Depression</kwd>
<kwd>Bacteria</kwd>
<kwd>Antibiotics</kwd>
<kwd>Monoamines</kwd>
<kwd>FOXG1</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media, LLC, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p>A key goal of biomedical research is to identify a common set of causative factors that is directly linked to pathophysiological changes observed in major neurodegenerative diseases afflicting human populations. A hallmark example identifies the major etiological factor in Parkinson’s disease (PD) as a relatively slow temporal loss of striatal dopaminergic (DA-ergic) transmission, resulting from a degeneration of neuronal somata located in the substantia nigra (Fearnley and Lees <xref ref-type="bibr" rid="CR25">1991</xref>). Furthermore, a wealth of published biochemical, cellular, and molecular studies, is focused on pathophysiological changes in mitochondrial function linked to diminished cellular bioenergetics, free radical generation, impaired protein transport and metabolism, and diminished mitochondrial biogenesis as key causative factors in PD development (Giannoccaro et al. <xref ref-type="bibr" rid="CR29">2017</xref>; McWilliams and Muqit <xref ref-type="bibr" rid="CR55">2017</xref>; Smith et al. <xref ref-type="bibr" rid="CR80">2017</xref>; Winklhofer and Haass <xref ref-type="bibr" rid="CR104">2010</xref>). Currently, a burst of empirical investigation and critical thinking has focused on elucidating functional aspects of the intestinal microbiota in maintaining ongoing physiological processes within the gastrointestinal (GI) tract (Hyland and Cryan <xref ref-type="bibr" rid="CR33">2016</xref>; Obata and Pachnis <xref ref-type="bibr" rid="CR61">2016</xref>; Yano et al. <xref ref-type="bibr" rid="CR109">2015</xref>). Of equivalent importance, the integrity of bidirectional gut–brain signaling pathways appears to be dependent on a functionally active, healthy, microbiome (Diaz Heijtz et al. <xref ref-type="bibr" rid="CR18">2011</xref>; Zhou and Foster <xref ref-type="bibr" rid="CR112">2015</xref>) and dysbiosis of the human gut microbiota has been functionally associated with central nervous system (CNS) degenerative disorders that include PD (Bedarf et al. <xref ref-type="bibr" rid="CR4">2017</xref>; Devos et al. <xref ref-type="bibr" rid="CR17">2013</xref>; Forsyth et al. <xref ref-type="bibr" rid="CR26">2011</xref>; Malkki <xref ref-type="bibr" rid="CR50">2017</xref>; Mulak and Bonaz <xref ref-type="bibr" rid="CR59">2015</xref>; Rietdijk et al. <xref ref-type="bibr" rid="CR70">2017</xref>; Scheperjans et al. <xref ref-type="bibr" rid="CR75">2015</xref>), Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis (Main and Minter <xref ref-type="bibr" rid="CR49">2017</xref>; Tremlett et al. <xref ref-type="bibr" rid="CR95">2017</xref>).</p>
<p>The goal of this review is to highlight potential thematic/functional linkages of pathophysiological alterations in gut microbiota and bidirectional gut–brain signaling pathways with special emphasis on the potential roles of gut dysbiosis on the pathophysiology of psychiatric illnesses. We provide a concise discussion of evolutionarily conserved, intrinsic DA-ergic, 5-HT-ergic, and GABA-ergic signaling pathways between gut microbiota, enteric neurons, and enterochromaffin (EC) cells, that partially mediate homeostasis of innate immunity (Petra et al. <xref ref-type="bibr" rid="CR67">2015</xref>; Reigstad et al. <xref ref-type="bibr" rid="CR69">2015</xref>; Scheperjans et al. <xref ref-type="bibr" rid="CR75">2015</xref>; Stefano et al. <xref ref-type="bibr" rid="CR90">1976</xref>). This is followed by a concise review of comorbid pathophysiological events preceding observed motor symptoms associated with PD that include concerted dysregulation of GI function via dysbiosis of gut microbiota, loss of intrinsic ENS/lymphoid coupling, severely diminished immune competence, and progressive colonic inflammation. Furthermore, we provide critical discussion of putative thematic linkages of PD data sets to similar pathophysiological events as potential causative factors in the development and persistence of diverse psychiatric illnesses. Finally, we include a concise review of preclinical paradigms that involve immunologically induced GI deficits and dysbiosis of maternal microflora that are functionally linked to impaired neurodevelopmental processes leading to affective behavioral syndromes in the offspring.</p>
</sec>
<sec id="Sec2">
<title>Biogenic Amine Signaling Linkages of Gut Microbiota, Neurons, and Lymphoid Tissues</title>
<p>We have previously contended that the retention of a core of archetypal chemical messengers across animal and plant phyla represents a likely mechanistic driving force for evolutionary expansion of complex cellular systems (Stefano <xref ref-type="bibr" rid="CR84">1986</xref>; Stefano and Kream <xref ref-type="bibr" rid="CR85">2007</xref>, <xref ref-type="bibr" rid="CR86">2010</xref>). The biological elegance of dopamine (DA; 3,4-dihydroxyphenylethylamine) resides in its pivotal role as a prototype chemical mediator of diverse signaling and metabolic events including locomotor behaviors across a wide spectrum of animal phyla (Kutchko and Siltberg-Liberles <xref ref-type="bibr" rid="CR40">2013</xref>; Rivard et al. <xref ref-type="bibr" rid="CR71">2010</xref>; Stefano et al. <xref ref-type="bibr" rid="CR90">1976</xref>; Stefano and Kream <xref ref-type="bibr" rid="CR85">2007</xref>). Although studies designed to directly assess the regulatory roles of free DA released within the lumen of the gut remain scarce (Roshchina <xref ref-type="bibr" rid="CR73">2010</xref>), it appears that the contributions of several species of microbiota to maintain normative DA concentrations are of critical importance to maintenance of innate immunity involving the enteric nervous system (ENS) and mucosal lymphoid tissues (Hyland and Cryan <xref ref-type="bibr" rid="CR33">2016</xref>; Mittal et al. <xref ref-type="bibr" rid="CR57">2017</xref>; Mulak and Bonaz <xref ref-type="bibr" rid="CR59">2015</xref>; Obata and Pachnis <xref ref-type="bibr" rid="CR61">2016</xref>; Yoo and Mazmanian <xref ref-type="bibr" rid="CR110">2017</xref>). Interestingly, a recent preclinical model of antibiotic-induced dysbiosis linked to severe ENS damage and impaired GI function in young mice raises significant concern relating to widespread usage of antibiotics in children and potential dysregulation of bidirectional gut–CNS signaling systems in later life (Caputi et al. <xref ref-type="bibr" rid="CR11">2017</xref>; Stefano et al. <xref ref-type="bibr" rid="CR92">2017</xref>).</p>
<p>Serotonin (5-hydroxytryptamine or 5-HT) is a multifunctional biogenic amine with neuronal and endocrine signaling roles in a range of GI physiological pathways (Martin et al. <xref ref-type="bibr" rid="CR53">2017</xref>). Over 90% of whole body 5-HT is synthesized within populations of EC cells and neurons of the ENS distributed throughout superficial and deeper layers of the GI tract. EC cells appear to integrate nutritional cues with ENS activity and gut microbiome homeostasis via signaling processes mediated by multiple 5-HT receptor types and subtypes (Martin et al. <xref ref-type="bibr" rid="CR53">2017</xref>; Mawe and Hoffman <xref ref-type="bibr" rid="CR54">2013</xref>). Dysregulation of integrated 5-HT signaling pathways within the gut has been functionally linked to an array of pathophysiological conditions (Mawe and Hoffman <xref ref-type="bibr" rid="CR54">2013</xref>).</p>
<p>Within the gut, biosynthesis of 5-HT within EC cells and ENS neurons is catalyzed by 2 isozymes of tryptophan hydroxylase (Tph), Tph1 and Tph2, respectively (Martin et al. <xref ref-type="bibr" rid="CR53">2017</xref>). Furthermore, biosynthesis of chemically authentic 5-HT has been demonstrated in the following strains of gut microflora: <italic>Lactococcus lactis, Lactobacillus plantarum, Streptococcus thermophiles, Escherichia coli</italic> K-12, <italic>Morganella morganii, Klebsiella pneumonia, Hafnia alvei</italic> (Özoğul <xref ref-type="bibr" rid="CR65">2004</xref>; Shishov et al. <xref ref-type="bibr" rid="CR78">2009</xref>). The bacterial production of 5-HT occurs independently of tryptophan hydroxylase (THPH) via decarboxylation of tryptophan to tryptamine, as seen in plants (Shishov et al. <xref ref-type="bibr" rid="CR78">2009</xref>). Temporally and spatially defined release of 5-HT from EC cells, ENS neurons, and gut microbiota may differentially activate 14 different 5-HT receptor subtypes located on ENS neurons and immune cells. Furthermore, blood borne 5-HT evolving from the GI tract is sequestered by circulating platelets, maintaining hemostasis via platelet aggregation that ultimately affects immune competence, bone marrow development and cardiac function (Baganz and Blakely <xref ref-type="bibr" rid="CR1">2013</xref>; Gershon and Tack <xref ref-type="bibr" rid="CR28">2007</xref>; Hoffman et al. <xref ref-type="bibr" rid="CR30">2012</xref>; Mawe and Hoffman <xref ref-type="bibr" rid="CR54">2013</xref>). Importantly, pathogenic strains of <italic>E. coli</italic> have been observed to inhibit intestinal 5-HT transporter function and expression, thereby confirming the critical role of reciprocal 5-HT signaling processes within the gut (Esmaili et al. <xref ref-type="bibr" rid="CR23">2009</xref>).</p>
<p>It has been previously demonstrated that gut microflora partially regulate 5-HT biosynthesis by host cells (Yano et al. <xref ref-type="bibr" rid="CR109">2015</xref>). Notably, short chain fatty acids (SCFA) evolving from fermentation processes of gut enterotypes such as Prevotella copri may induce Tph1 gene expression by EC cells (Reigstad et al. <xref ref-type="bibr" rid="CR69">2015</xref>). Additionally, commensal bacterial enterotypes such as Bifidobacterium infantis, can modulate tryptophan metabolism and influence the essential precursor pool for 5-HT production within the GI system (Diaz Heijtz et al. <xref ref-type="bibr" rid="CR18">2011</xref>). Regulation of 5-HT transporter (SERT) gene expression in the intestinal epithelium has been shown to differ from that of neuronal SERT gene expression (Hoffman et al. <xref ref-type="bibr" rid="CR30">2012</xref>; Mawe and Hoffman <xref ref-type="bibr" rid="CR54">2013</xref>) and infection with enteropathogenic strains of <italic>E coli</italic> alters SERT gene expression in vivo. These observations provide a potential model for investigating the regulation of SERT as an effective pharmacological target for several GI disorders (Esmaili et al. <xref ref-type="bibr" rid="CR23">2009</xref>; Li and Young <xref ref-type="bibr" rid="CR45">2013</xref>) and comorbid CNS behavioral syndromes that are partially dependent on altered gut–brain signaling processes.</p>
<p>Gamma-aminobutyric acid (GABA) expression within the gut mediates critical regulatory activities between the ENS and lymphoid tissues involved in immune competence via T cell responses (De Biase and Pennacchietti <xref ref-type="bibr" rid="CR14">2012</xref>). Contrary to its marked role within CNS structures, GABA mediates neuronal excitability within the ENS via activation of GABA-GABA<sub>A</sub> receptor systems (De Biase and Pennacchietti <xref ref-type="bibr" rid="CR14">2012</xref>; Hyland and Cryan <xref ref-type="bibr" rid="CR33">2016</xref>). Infective microbiota, including <italic>E. coli, Listeria monocytogenes, Shigella flexneri</italic>, and <italic>Lactococcus lactis</italic> depend for their transit through the digestive system on the glutamate-dependent acid resistance mechanism (GDAR). Intraluminal GABA production and release by commensal lactobacilli provides an essential protective mechanism against infective bacteria via GDAR inhibition. In effect, selective strains of commensal microbiota may differentially influence ENS activity via diverse GABA-ergic mechanisms (Hyland and Cryan <xref ref-type="bibr" rid="CR33">2016</xref>).</p>
</sec>
<sec id="Sec3">
<title>Pro-inflammatory Processes Initiated by Alterations in Gut Signaling Pathways</title>
<p>In the preceding section, we have highlighted the biological necessity of maintaining reciprocal communication processes within microenvironments of the gut via retention and selective adaptations of biogenic amine signaling pathways. As depicted in Fig. <xref ref-type="fig" rid="Fig1">1</xref>, commensal enterotypes situated at the luminal surface of the gut mediate essential regulatory activities that coordinate neural and immune function by populations of enterochromaffin cells and ENS neurons via usage of common signal molecules and cells (de Muinck et al. <xref ref-type="bibr" rid="CR16">2017</xref>; Stefano et al. <xref ref-type="bibr" rid="CR91">1994</xref>). Physiological perturbations of normal gut functioning require minute readjustments of this defined regulatory loop to achieve basal levels of signaling activity with appropriate restoration of intrinsic ratios of microbiota.</p>
<p>
<fig id="Fig1"><label>Fig. 1</label><caption><p>Bacterial intrinsic ratio perturbations are normal occurrences in the microbiome. In part, this phenomenon is monitored by the enteric microglia found in Auerbach’s and Meissner’s plexus. Macrophages freely travel via the circulatory system and gain entrance into the enteric nervous system and reside there fulfilling their sentinel function by transforming into microglia as also occurs in the brain. Clearly, as in the brain, various chemical messengers (e.g., LPS from bacteria) or toxins can activate these cellular sentinels turning them back into macrophages to meet the micro-environmental challenge. Activated macrophages originating from the enteric neuroimmune system may also enter the brain and by so doing activate central nervous system neurons and microglia. For example, the nucleus tractus solitarius is especially susceptible. This abnormal or normal activation may exert profound influences on regions of the brain, controlling our mental processes and consciousness because these activities are always on and thus subject to immediate modification. It is equally important to note that eukaryotic cell mitochondria may be part of this intricate communication between the host and the micro biota. Given the origin of mitochondria as a prokaryotic cell, its ability to communicate bidirectionally with a bacterium also exists and occurs</p></caption><graphic id="d29e608" xlink:href="10571_2018_589_Fig1_HTML"></graphic></fig>
</p>
<p>Conversely, acute and chronic pathophysiological disruptions of this short intraluminal regulatory loop are functionally linked to severe dysfunction of multiple cell types and microflora, ultimately compromising ENS neuronal activities within the submuscosal and muscularis layers of the colon. Accordingly, a focal point of homeostatic maintenance of essential activities of interactive cell types and microflora rests on the integrity of tight junctions (TJs) situated at the apical surface of adjacent epithelial cells within the lumen of the gut (Coleman and Haller <xref ref-type="bibr" rid="CR13">2017</xref>; Wells et al. <xref ref-type="bibr" rid="CR103">2017</xref>). Pathophysiological alterations of barrier permeability have been demonstrated to initiate cascades of pro-inflammatory insults to intrinsic cells within superficial and deeper layers, with severe consequences to normal bidirectional gut-brain signaling processes. The essential roles of specific TJ proteins on maintaining normative epithelial permeability, notably zona occludens proteins 1–3, have been demonstrated (Ivanov <xref ref-type="bibr" rid="CR34">2012</xref>) and TJ dysfunction has been associated with hyper-permeability functionally linked to the induction and overexpression of key inflammatory cytokines including interferon-gamma, TNF-alpha, IL-1beta, and IL-17 (Manoharan et al. <xref ref-type="bibr" rid="CR51">2016</xref>) and underepressiion of anti-inflammatory IL-10 (Ray and Dittel <xref ref-type="bibr" rid="CR68">2015</xref>). Furthermore, loss of epithelial barrier integrity is critically linked to perturbation of immune homeostasis and normative generation of regulatory T (Treg) cells from activated CD103<sup>+</sup> dendritic cells (DCs), resulting in enhanced inflammatory Th1/Th17 responses that are reciprocally linked to severe dysbiosis of commensal microbiota (Barthels et al. <xref ref-type="bibr" rid="CR2">2017</xref>; Omenetti and Pizarro <xref ref-type="bibr" rid="CR64">2015</xref>).</p>
<p>Production of immune modulators due to pro-inflammatory events is compounded by metabolic insufficiencies linked to Type II diabetes and/or inadequate dietary regimens (Noble et al. <xref ref-type="bibr" rid="CR60">2017</xref>) or diminished SCFA production and release by dysbiotic microflora (Kelly et al. <xref ref-type="bibr" rid="CR37">2015</xref>; Tulstrup et al. <xref ref-type="bibr" rid="CR96">2015</xref>). Resultant downregulation and production of luminal secretory immunoglobulin A (sIgA) and antimicrobial peptides and proteins (AMPs) permit passage of pathogenic microorganisms and pro-inflammatory toxins such as lipopolysaccharide (LPS) through a compromised epithelial barrier into the submucosa and peripheral circulation (Coleman and Haller <xref ref-type="bibr" rid="CR13">2017</xref>; Wells et al. <xref ref-type="bibr" rid="CR103">2017</xref>). Finally, a recent preclinical study utilizing zebrafish as a developmental model system, has demonstrated that genetic modulation of ENS function due to a mutation in the Hirschsprung disease gene, sox10, results in microbiota-dependent inflammation (Rolig et al. <xref ref-type="bibr" rid="CR72">2017</xref>). Enhanced pro-inflammatory processes were associated with altered intrinsic ratios of pro-inflammatory to anti-inflammatory bacterial lineages, thereby demonstrating a critical role of normative ENS physiology to maintain a healthy gut microbiome.</p>
<p>It is apparent that the host organism has evolved mechanisms to sense when potentially deleterious perturbations of gut physiology may lead to chronic pathophysiological states (Verheijden et al. <xref ref-type="bibr" rid="CR98">2015</xref>) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). In part, these monitoring processes may occur by activation of enteric microglia found in Auerbach’s and Meissner’s plexuses that are key players in the maintenance of innate immunity (Verheijden et al. <xref ref-type="bibr" rid="CR98">2015</xref>). Local sustained release of pro-inflammatory mediators within microenvironments of the gut provides a switching mechanism for converting enteric microglia into active immune cells with macrophage-like phenotypic expression (Sonetti et al. <xref ref-type="bibr" rid="CR82">1994</xref>; Stefano et al. <xref ref-type="bibr" rid="CR91">1994</xref>). Interestingly, circulating macrophages may gain entrance into the ENS and reside there fulfilling their innate immune function via transformation into enteric microglia (Verheijden et al. <xref ref-type="bibr" rid="CR98">2015</xref>). Similar to ongoing CNS immune processes, various chemical messengers (e.g., lipopolysaccharide released from circulating bacteria or gut microbiota) can activate these cellular sentinels turning them back into macrophages in order to adequately address micro-environmental challenges (Le et al. <xref ref-type="bibr" rid="CR43">2001</xref>; Stefano et al. <xref ref-type="bibr" rid="CR91">1994</xref>; Verheijden et al. <xref ref-type="bibr" rid="CR98">2015</xref>). We contend that prolonged pro-inflammatory stimuli activate greater numbers of activated microglia to yield enhanced concentrations of circulating macrophages. As previously noted (Stefano et al. <xref ref-type="bibr" rid="CR91">1994</xref>), enhanced populations of circulating macrophages that have originated from the enteric immune and nervous systems may ultimately activate CNS neurons and glia. For example, the nucleus tractus solitarius (NTS) of the brainstem is especially susceptible to immune influences with resultant aberrant modulation of essential autonomic regulatory activities (Dworak et al. <xref ref-type="bibr" rid="CR22">2014</xref>) (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Rostral transmission of aberrant NTS activation may exert profound influences on regions of the brain regulating integrated cognitive and behavioral processes (Bieri et al. <xref ref-type="bibr" rid="CR5">2017</xref>; Lamberts et al. <xref ref-type="bibr" rid="CR41">2015</xref>). Additionally, alterations of normative neural-immune signaling processes within the gut–brain axis may be susceptible to poor dietary regimens via modulation of essential ratios of gut microbiota.</p>
<p>
<fig id="Fig2"><label>Fig. 2</label><caption><p>By way of vagal enteric stimulation normal neural pathways may also be susceptible to abnormal microglial conversions into macrophages, inducing enhanced excitation at the peripheral level (e.g., enteric plexi). In this instance, this rapid neural response may also manifest itself via the nucleus tractus solitarius and locus coeruleus, which would influence the amygdala, hippocampus and the thalamus, and ultimately the cortex</p></caption><graphic id="d29e714" xlink:href="10571_2018_589_Fig2_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec4">
<title>Dysregulation of Gut Signaling Processes as Potential Etiological Factors in Parkinson’s Disease</title>
<p>Comorbid pathophysiological events preceding observed motor symptoms associated with PD include concerted dysregulation of GI function via dysbiosis of gut microbiota, loss of intrinsic ENS/lymphoid coupling, severely diminished immune competence, and progressive colonic inflammation (Bodea et al. <xref ref-type="bibr" rid="CR6">2014</xref>; Braak et al. <xref ref-type="bibr" rid="CR10">2003</xref>; Dobbs et al. <xref ref-type="bibr" rid="CR21">1999</xref>; Forsyth et al. <xref ref-type="bibr" rid="CR26">2011</xref>; Kosikowska et al. <xref ref-type="bibr" rid="CR39">2016</xref>; Lebouvier et al. <xref ref-type="bibr" rid="CR44">2009</xref>; Rietdijk et al. <xref ref-type="bibr" rid="CR70">2017</xref>; Villaran et al. <xref ref-type="bibr" rid="CR100">2010</xref>). In light of the above, chronic expression of activated macrophages within the submucosal and muscularis layers of the colon may mediate profound degenerative changes within neurons and glia of the ENS (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Accordingly, it has been hypothesized that the slow progression of degenerative changes in the gut is coordinately transmitted via long peripheral nerve and humoral regulatory loops into the CNS, with resultant degeneration of DA-ergic somata of the nigrostriatal CNS pathway (Braak and Del Tredici <xref ref-type="bibr" rid="CR9">2017</xref>; Braak et al. <xref ref-type="bibr" rid="CR10">2003</xref>; Rietdijk et al. <xref ref-type="bibr" rid="CR70">2017</xref>). Recent studies have indicated that PD progression involves pathophysiological disruption of sensory input into the NTS via unmyelinated vagal fibers (Bieri et al. <xref ref-type="bibr" rid="CR5">2017</xref>; Lamberts et al. <xref ref-type="bibr" rid="CR41">2015</xref>) and subsequent noradrenergic transmission emanating from the locus coeruleus (LC) in the brainstem (Braak and Del Tredici <xref ref-type="bibr" rid="CR9">2017</xref>; Vermeiren and De Deyn <xref ref-type="bibr" rid="CR99">2017</xref>) (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Furthermore, in a preclinical rat model of PD, vagal nerve stimulation was observed to significantly enhance locomotor activity that was accompanied by increased tyrosine hydroxylase expression and decreased neuroinflammation in the nigrostriatal system (Farrand et al. <xref ref-type="bibr" rid="CR24">2017</xref>). Finally, closer examination of the putative gut–CNS anatomical pathway outlined in the original hypothesis of PD induction by Braak and coworkers (Braak et al. <xref ref-type="bibr" rid="CR10">2003</xref>) may provide us with a working model of a normative bidirectional anterograde and retrograde signaling pathway linking limbic and cortical CNS groupings with gut microbiota and the ENS.</p>
<p>Several studies have attempted to functionally link progressive stages of PD with changes in intrinsic ratios of gut microbiota (Scheperjans et al. <xref ref-type="bibr" rid="CR75">2015</xref>). Notable associations include marked reductions in the abundance of Prevotellaceae/Prevotella species and Bacteroidaceae/Bacteroides species in fecal specimens of PD patients (Scheperjans et al. <xref ref-type="bibr" rid="CR75">2015</xref>) and patients displaying active symptoms of inflammatory bowel syndrome [IBS, (Mertsalmi et al. <xref ref-type="bibr" rid="CR56">2017</xref>)], as compared to healthy controls. Conversely, increases in the relative abundance of Enterobacteriaceae members were positively correlated with the severity of PD-related motor deficits (Bedarf et al. <xref ref-type="bibr" rid="CR4">2017</xref>; Scheperjans et al. <xref ref-type="bibr" rid="CR75">2015</xref>), comorbid inflammatory processes (Mertsalmi et al. <xref ref-type="bibr" rid="CR56">2017</xref>; Unger et al. <xref ref-type="bibr" rid="CR97">2016</xref>), and observable decreases in SCFA production by affected microbiota (Unger et al. <xref ref-type="bibr" rid="CR97">2016</xref>).</p>
<p>Interestingly, concerted studies designed to associate established dietary patterns with alterations in Bacteroides and Prevotella enterotypes may provide a functional handle linking the observed changes in species of gut microbiota of PD patients to chronic pathophysiological events involved in disease progression (Wu et al. <xref ref-type="bibr" rid="CR106">2013</xref>, <xref ref-type="bibr" rid="CR105">2011</xref>). Differential expression of Bacteroides versus Prevotella enterotypes was strongly associated with proto-Western diets enriched in protein and animal fat as compared to proto-agrarian diets enriched in simple and conjugated carbohydrates, respectively (Wu et al. <xref ref-type="bibr" rid="CR105">2011</xref>). Accordingly, the putative pathophysiological role of environmentally determined deficiencies of dietary components on altering essential ratios of human gut microbiota, notably Prevotella and Bacteroides oligotypes, appears to be intimately associated with pro-inflammatory processes underlying IBS and PD progression (Wu et al. <xref ref-type="bibr" rid="CR106">2013</xref>).</p>
</sec>
<sec id="Sec5">
<title>Comorbid Etiological Factors in Impaired Gut Physiology of Patients Afflicted with Affective Disorders</title>
<p>As discussed above, lessons learned from concerted PD studies of comorbid alterations in gut physiology, dysbiosis of commensal microbiota, and degenerative changes in ENS neurons and glia may be judiciously applied to investigation of diverse psychiatric illnesses. Critical assessment of PD data sets may provide us with putative thematic linkages to evaluate similar pathophysiological events as potential causative factors in the development of Affective Spectrum Disorders (AfSD). Prefrontal cortical and hippocampal regions are densely innervated by rostral noradrenergic projections from LC neurons and have been established to mediate complex cognitive behaviors that are effectively compromised in neurodegenerative and psychiatric diseases (Borodovitsyna et al. <xref ref-type="bibr" rid="CR7">2017</xref>). Recent clinical studies confirm the efficacy of vagal nerve stimulation for major depressive disorder (Carreno and Frazer <xref ref-type="bibr" rid="CR12">2017</xref>; Lucas et al. <xref ref-type="bibr" rid="CR47">2017</xref>; Salloum et al. <xref ref-type="bibr" rid="CR74">2017</xref>) and AfSD (Jin and Kong <xref ref-type="bibr" rid="CR35">2017</xref>) as mediated by sensory activation of the NTS of the brainstem that directly projects to LC neurons (Beaumont et al. <xref ref-type="bibr" rid="CR3">2017</xref>; Yakunina et al. <xref ref-type="bibr" rid="CR107">2017</xref>). We therefore contend that a convergence of multidisciplinary studies suggests the existence of bidirectional gut–brain signaling pathways dependent upon efferent vagal/ENS transmission linked to reciprocal sensory vagal stimulation of discrete brainstem nuclei that project to rostral CNS areas involved with cognition and complex behaviors (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Finally, we postulate that dysregulation of bidirectional gut–brain signaling is critically linked to the etiology of AfSD and other psychiatric illnesses.</p>
<p>Several lines of preclinical and clinical evidence have made strong case for the involvement of dysregulated GI function with associated colonic inflammation and dysbiosis of gut microbiota in the etiology and progression of AfSD and related psychiatric disorders (Diaz Heijtz et al. <xref ref-type="bibr" rid="CR18">2011</xref>; Frohlich et al. <xref ref-type="bibr" rid="CR27">2016</xref>; Petra et al. <xref ref-type="bibr" rid="CR67">2015</xref>; Zheng et al. <xref ref-type="bibr" rid="CR111">2016</xref>; Zhou and Foster <xref ref-type="bibr" rid="CR112">2015</xref>). Furthermore, collected studies from the laboratories of Cryan, Dinan, and collaborators, have provided a mechanistic framework for evaluating the effects of dysbiotic microflora and gut inflammation on altered vagal signaling leading to induction and persistence of CNS behavioral disorders (Borre et al. <xref ref-type="bibr" rid="CR8">2014</xref>; Dinan and Cryan <xref ref-type="bibr" rid="CR19">2017</xref>; Dinan et al. <xref ref-type="bibr" rid="CR20">2015</xref>; Kelly et al. <xref ref-type="bibr" rid="CR38">2016</xref>; Sherwin et al. <xref ref-type="bibr" rid="CR77">2016</xref>). As discussed earlier, it appears that altered vagal outflow is functionally linked to cascading pro-inflammatory processes driven by pathophysiological alterations in the luminal epithelial barrier (Coleman and Haller <xref ref-type="bibr" rid="CR13">2017</xref>; Wells et al. <xref ref-type="bibr" rid="CR103">2017</xref>). Furthermore, dysbiosis of gut microbiota mediates significant alterations in 5-HT signaling and tryptophan metabolism (O’Mahony et al. <xref ref-type="bibr" rid="CR63">2015</xref>), leading to hyper-excitability of vagal fibers, dysregulation of enterochromaffin cells, and ENS activity (Hyland and Cryan <xref ref-type="bibr" rid="CR33">2016</xref>). Finally, a recent preclinical study from this group sought to evaluate the effects of altered vagal activity on brain-derived neurotrophic factor (BDNF) expression in the hippocampus (O’Leary et al. <xref ref-type="bibr" rid="CR62">2018</xref>). The authors observed that vagotomy decreased BDNF mRNA expression throughout mouse hippocampus and was associated impaired development of immature neurons displaying complex dendritic morphology. The authors concluded that vagal nerve activity influences neurogenesis via BDNF expression in the hippocampus, thereby providing a cogent model for pathophysiological downregulation of neural plasticity that is associated with severe alterations in the gut-brain-microbiome bidirectional signaling pathway.</p>
<p>In light of these findings, analysis of fecal samples from children with autistic symptoms revealed augmented levels of three Clostridium clusters and one Clostridium species, <italic>C. bolteae</italic>, consistent with chronic dysbiosis of the microbiome (Shaw <xref ref-type="bibr" rid="CR76">2016</xref>; Song et al. <xref ref-type="bibr" rid="CR83">2004</xref>). High concentrations of Clostridia metabolites and bacterially expressed chemical toxins such as p-cresol have also been associated with various psychiatric disorders and PD (Persico and Napolioni <xref ref-type="bibr" rid="CR66">2013</xref>; Shaw <xref ref-type="bibr" rid="CR76">2016</xref>). In this instance, Clostridia metabolites have the ability to inhibit dopamine-beta-hydroxylase, increasing DA levels, and oxidative molecules damaging neuronal mitochondria (Shaw <xref ref-type="bibr" rid="CR76">2016</xref>). Furthermore, ingestion of herbicide-derived glyphosate has observed to promote toxic dysbiosis of gut microbiota associated with adverse psychiatric symptoms (Shaw <xref ref-type="bibr" rid="CR76">2016</xref>; Song et al. <xref ref-type="bibr" rid="CR83">2004</xref>). From a biochemical perspective, bacterial homologs of eukaryotic plasma membrane-associated monoamine transporters appear to play a functional role in the disposition and metabolism of DA and 5-HT within the lumen and mucosal layers of the gut (Yamashita et al. <xref ref-type="bibr" rid="CR108">2005</xref>). Dysbiosis of gut microbiota associated with altered regulation of monoamine metabolism has been implicated in neurological and neuropsychiatric illnesses (Singh and Pal <xref ref-type="bibr" rid="CR79">2015</xref>). Relatively recent clinical and preclinical studies demonstrate limited efficacies of probiotic treatments (Kang et al. <xref ref-type="bibr" rid="CR36">2017</xref>; Liu et al. <xref ref-type="bibr" rid="CR46">2016</xref>; Wallace and Milev <xref ref-type="bibr" rid="CR102">2017b</xref>) and fecal microbiota transplants (Kang et al. <xref ref-type="bibr" rid="CR36">2017</xref>) on reduction of adverse behavioral symptoms associated with AfSD.</p>
<p>From a neurodevelopmental perspective, a recent preclinical rodent study has demonstrated that trans-placental exposure of the fetal brain to circulating bacterial peptidoglycan released from the maternal gut microbiome mediates cognitive and behavioral disorders in the offspring (Humann et al. <xref ref-type="bibr" rid="CR32">2016</xref>). The authors hypothesize that that moderate to severe dysregulation of maternally derived innate immunity that is functionally associated with dysbiosis of gut microbiota results in release of a potent pro-inflammatory mediator, i.e., bacterial peptidoglycan, that profoundly affects cortical development of the fetal brain via disruption of FOXG1 gene expression (Bodea et al. <xref ref-type="bibr" rid="CR6">2014</xref>; Humann et al. <xref ref-type="bibr" rid="CR32">2016</xref>). The FOXG1 gene encodes a brain-specific transcriptional activator protein, which plays an important role in cortical CNS development (De Filippis et al. <xref ref-type="bibr" rid="CR15">2012</xref>) and animal offspring, so exposed, exhibit decreased cognitive function. Furthermore, it has been empirically demonstrated that FOXG1 overexpression may initiate a dysregulation of GABA/glutamate neuronal differentiation and overproduction of GABA-ergic inhibitory neurons, thereby contributing to established symptomatology associated with AfSD (Mariani et al. <xref ref-type="bibr" rid="CR52">2015</xref>). Employment of a different preclinical mouse model has linked immunologically induced maternal GI barrier defects with resulting neuro-developmentally linked behavioral disorders in the offspring (Hsiao <xref ref-type="bibr" rid="CR31">2013</xref>). The study demonstrates that oral treatment of behaviorally impaired offspring with strains of human commensal Bacteroides fragilis altered ratios of gut microbiota with amelioration of defects in communicative and stereotypic sensorimotor behaviors.</p>
<p>Finally, dysbiosis of essential strains of gut microflora engendered by dysregulation of biogenic amine signaling pathways may negatively affect essential gut–CNS communication processes at multiple physiological check points that modulate mitochondrial bioenergetics (Petra et al. <xref ref-type="bibr" rid="CR67">2015</xref>; Reigstad et al. <xref ref-type="bibr" rid="CR69">2015</xref>; Scheperjans et al. <xref ref-type="bibr" rid="CR75">2015</xref>; Snyder et al. <xref ref-type="bibr" rid="CR81">2015</xref>; Wallace and Milev <xref ref-type="bibr" rid="CR101">2017a</xref>; Zheng et al. <xref ref-type="bibr" rid="CR111">2016</xref>; Zhou and Foster <xref ref-type="bibr" rid="CR112">2015</xref>). Recent studies have attempted to elucidate functional associations of impaired mitochondrial function (Stefano and Kream <xref ref-type="bibr" rid="CR89">2016</xref>; Tobe <xref ref-type="bibr" rid="CR94">2013</xref>) and/or dysbiosis of gut microflora in the etiology and/or progression of diverse psychiatric and related medical conditions subsumed under the general rubric of AfSD (Thompson et al. <xref ref-type="bibr" rid="CR93">2015</xref>; Tobe <xref ref-type="bibr" rid="CR94">2013</xref>). Accordingly, the predominant focus of the multi-generation pharmacopeia of clinically employed therapeutic agents for AfSD-related psychiatric disorders involves functional targeting of dysregulated DA-ergic and interactive biogenic amine signaling systems in cortical and limbic CNS areas (Moonen et al. <xref ref-type="bibr" rid="CR58">2017</xref>). Several of these classes of therapeutic agents have been observed to partially restore pathophysiological changes in mitochondrial bioenergetics associated with AfSD in discrete CNS areas (Stefano and Kream <xref ref-type="bibr" rid="CR88">2015a</xref>, <xref ref-type="bibr" rid="CR87">b</xref>). In contrast, there is a significant lack of empirical studies designed to evaluate the effects of commonly used antidepressant and neuroleptic agents on AfSD-associated gut dysbiosis (Macedo et al. <xref ref-type="bibr" rid="CR48">2017</xref>).</p>
</sec>
<sec id="Sec6" sec-type="conclusion">
<title>Conclusion</title>
<p>Operationally, stereo-selective conformational matching between coupled physiological processes of bacterial microflora and intrinsic GI cells appear to support the conservation of a critically important set of chemical messengers required for existential regulation of homeostatic cellular processes within GI and CNS tissues (Stefano et al. <xref ref-type="bibr" rid="CR92">2017</xref>). Accordingly, it is not surprising to find that alterations in microbiome-based metabolic processes ultimately affect bidirectional communication between peripheral organs and CNS structures, thereby underlining the presence of potential common pathophysiological factors in psychiatric and GI disorders. Bacteria also have the ability to exchange their genomic information, providing a process for maintaining common signaling resulting in their selective survival (Lang and Beatty <xref ref-type="bibr" rid="CR42">2000</xref>). Alterations in essential ratios of gut enterotypes may directly affect activation states and cell surface markers of resident macrophages/microglia contained within CNS and ENS structures, thereby modulating bidirectional communication processes (Stefano et al. <xref ref-type="bibr" rid="CR91">1994</xref>) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Finally, a more global view indicates a potential window of opportunity for development of novel therapeutic agents targeting microbiome, neurons, immune components, and the influence this has on brain function as a significant causative factor in severe behavioral disorders.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>5HT</term>
<def>
<p>5-hydroxytryptamine</p>
</def>
</def-item>
<def-item>
<term>AfSD</term>
<def>
<p>Affective spectrum disorders</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>Central nervous system</p>
</def>
</def-item>
<def-item>
<term>DA</term>
<def>
<p>Dopamine</p>
</def>
</def-item>
<def-item>
<term>DA-ergic</term>
<def>
<p>Dopaminergic</p>
</def>
</def-item>
<def-item>
<term>FOXG1</term>
<def>
<p>Forkhead box protein G1</p>
</def>
</def-item>
<def-item>
<term>GABA</term>
<def>
<p>Gamma-aminobutyric acid</p>
</def>
</def-item>
<def-item>
<term>GAD</term>
<def>
<p>Glutamic acid decarboxylase</p>
</def>
</def-item>
<def-item>
<term>GDAR</term>
<def>
<p>The glutamate-dependent acid resistance mechanism</p>
</def>
</def-item>
<def-item>
<term>GI</term>
<def>
<p>Gastrointestinal</p>
</def>
</def-item>
<def-item>
<term>IGF1</term>
<def>
<p>Insulin like growth factor 1</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term>PI3</term>
<def>
<p>Phosphoinositide 3</p>
</def>
</def-item>
<def-item>
<term>RTT</term>
<def>
<p>Rett syndrome</p>
</def>
</def-item>
<def-item>
<term>SCFA</term>
<def>
<p>Short chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>SERT</term>
<def>
<p>Serotonin transporter</p>
</def>
</def-item>
<def-item>
<term>Tph</term>
<def>
<p>Tryptophan hydroxylase</p>
</def>
</def-item>
</def-list>
</glossary>
<notes notes-type="author-contribution">
<title>Author Contributions</title>
<p>GBS: Review Design, Data Interpretation, Manuscript Preparation, Literature Search; NP: Literature Search; RP: Data Interpretation; JR: Data Interpretation; MV: Literature Search; RMK: Review Design, Data Interpretation, Manuscript Preparation, Literature Search.</p>
</notes>
<notes notes-type="COI-statement">
<title>Compliance with Ethical Standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>George B. Stefano, Nastazja Pilonis, Radek Ptacek, Jiri Raboch, Martina Vnukova, and Richard M. Kream declare no conflicts of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baganz</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Blakely</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>A dialogue between the immune system and brain, spoken in the language of serotonin</article-title>
<source/>ACS Chem Neurosci
          <year>2013</year>
<volume>4</volume>
<fpage>48</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">23336044</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barthels</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD40-signalling abrogates induction of RORγt<sup>+</sup> Treg cells by intestinal CD103<sup>+</sup> DCs and causes fatal colitis</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<fpage>14715</fpage>
<pub-id pub-id-type="pmid">28276457</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaumont</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cervical vagus nerve stimulation augments spontaneous discharge in second- and higher-order sensory neurons in the rat nucleus of the solitary tract</article-title>
<source/>Am J Physiol Heart Circ Physiol
          <year>2017</year>
<volume>313</volume>
<fpage>H354-H367</fpage>
<pub-id pub-id-type="pmid">28476920</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedarf</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson’s disease patients</article-title>
<source/>Genome Med
          <year>2017</year>
<volume>9</volume>
<fpage>39</fpage>
<pub-id pub-id-type="pmid">28449715</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bieri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gitler</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Brahic</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Internalization, axonal transport and release of fibrillar forms of alpha-synuclein</article-title>
<source/>Neurobiol Dis
          <year>2017</year>
<pub-id pub-id-type="pmid">28323023</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bodea</surname>
<given-names>LG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurodegeneration by activation of the microglial complement-phagosome pathway</article-title>
<source/>J Neurosci
          <year>2014</year>
<volume>34</volume>
<fpage>8546</fpage>
<lpage>8556</lpage>
<pub-id pub-id-type="pmid">24948809</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borodovitsyna</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Flamini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Noradrenergic modulation of cognition in health and disease</article-title>
<source/>Neural Plast
          <year>2017</year>
<volume>2017</volume>
<fpage>6031478</fpage>
<pub-id pub-id-type="pmid">28596922</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borre</surname>
<given-names>YE</given-names>
</name>
<name>
<surname>Moloney</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>The impact of microbiota on brain and behavior: mechanisms &amp; therapeutic potential</article-title>
<source/>Adv Exp Med Biol
          <year>2014</year>
<volume>817</volume>
<fpage>373</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="pmid">24997043</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Del Tredici</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neuropathological staging of brain pathology in sporadic Parkinson’s disease: separating the wheat from the chaff</article-title>
<source/>J Park Dis
          <year>2017</year>
<volume>7</volume>
<fpage>S73S87</fpage>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rub</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Gai</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Del Tredici</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen</article-title>
<source/>J Neural Transm
          <year>2003</year>
<volume>110</volume>
<fpage>517</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="pmid">12721813</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caputi</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice</article-title>
<source/>Br J Pharmacol
          <year>2017</year>
<volume>174</volume>
<fpage>3623</fpage>
<lpage>3639</lpage>
<pub-id pub-id-type="pmid">28755521</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carreno</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Frazer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Vagal nerve stimulation for treatment-resistant</article-title>
<source/>Depress Neurother
          <year>2017</year>
<volume>14</volume>
<fpage>716</fpage>
<lpage>727</lpage>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coleman</surname>
<given-names>OI</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Bacterial signaling at the intestinal epithelial interface in inflammation and cancer</article-title>
<source/>Front Immunol
          <year>2017</year>
<volume>8</volume>
<fpage>1927</fpage>
<pub-id pub-id-type="pmid">29354132</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Biase</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pennacchietti</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Glutamate decarboxylase-dependent acid resistance in orally acquired bacteria: function, distribution and biomedical implications of the gadBC operon</article-title>
<source/>Mol Microbiol
          <year>2012</year>
<volume>86</volume>
<fpage>770</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="pmid">22995042</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Filippis</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expanding the phenotype associated with FOXG1 mutations and in vivo FoxG1 chromatin-binding dynamics</article-title>
<source/>Clin Genet
          <year>2012</year>
<volume>82</volume>
<fpage>395</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="pmid">22091895</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Muinck</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Lundin</surname>
<given-names>KEA</given-names>
</name>
<name>
<surname>Trosvik</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Linking spatial structure and community-level biotic interactions through cooccurrence and time series modeling of the human intestinal microbiota</article-title>
<source/>mSystems
          <year>2017</year>
<pub-id pub-id-type="pmid">28904999</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devos</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Colonic inflammation in Parkinson’s disease</article-title>
<source/>Neurobiol Dis
          <year>2013</year>
<volume>50</volume>
<fpage>42</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">23017648</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz Heijtz</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2011</year>
<volume>108</volume>
<fpage>3047</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="pmid">21282636</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome</article-title>
<source/>Neuropsychopharmacology
          <year>2017</year>
<volume>42</volume>
<fpage>178</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">27319972</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Collective unconscious: how gut microbes shape human behavior</article-title>
<source/>J Psychiatr Res
          <year>2015</year>
<volume>63</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">25772005</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobbs</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Charlett</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Purkiss</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Dobbs</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Weller</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism</article-title>
<source/>Acta Neurol Scand
          <year>1999</year>
<volume>100</volume>
<fpage>34</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">10416510</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dworak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stebbing</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kompa</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Krum</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Badoer</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction</article-title>
<source/>Auton Neurosci
          <year>2014</year>
<volume>185</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">24794248</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esmaili</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enteropathogenic <italic>Escherichia coli</italic> infection inhibits intestinal serotonin transporter function and expression</article-title>
<source/>Gastroenterology
          <year>2009</year>
<volume>137</volume>
<fpage>2074</fpage>
<lpage>2083</lpage>
<pub-id pub-id-type="pmid">19747920</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrand</surname>
<given-names>AQ</given-names>
</name>
<name>
<surname>Helke</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Gooz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hinson</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Boger</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson’s disease</article-title>
<source/>Brain Stimul
          <year>2017</year>
<pub-id pub-id-type="pmid">28918943</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fearnley</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Ageing and Parkinson’s disease: substantia nigra regional selectivity</article-title>
<source/>Brain
          <year>1991</year>
<volume>114</volume>
<issue>Pt 5</issue>
<fpage>2283</fpage>
<lpage>2301</lpage>
<pub-id pub-id-type="pmid">1933245</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forsyth</surname>
<given-names>CB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e28032</fpage>
<pub-id pub-id-type="pmid">22145021</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frohlich</surname>
<given-names>EE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>56</volume>
<fpage>140</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">26923630</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gershon</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Tack</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The serotonin signaling system: from basic understanding to drug development for functional GI disorders</article-title>
<source/>Gastroenterology
          <year>2007</year>
<volume>132</volume>
<fpage>397</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="pmid">17241888</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giannoccaro</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>La Morgia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Carelli</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson’s disease</article-title>
<source/>Mov Disord
          <year>2017</year>
<volume>32</volume>
<fpage>346</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="pmid">28251677</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity</article-title>
<source/>Gastroenterology
          <year>2012</year>
<volume>142</volume>
<fpage>844</fpage>
<lpage>854 e844</lpage>
<pub-id pub-id-type="pmid">22226658</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
</person-group>
<article-title>Immune dysregulation in autism spectrum disorder</article-title>
<source/>Int Rev Neurobiol
          <year>2013</year>
<volume>113</volume>
<fpage>269</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">24290389</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humann</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacterial peptidoglycan traverses the placenta to induce fetal neuroproliferation and aberrant postnatal behavior</article-title>
<source/>Cell Host Microbe
          <year>2016</year>
<volume>19</volume>
<fpage>901</fpage>
<pub-id pub-id-type="pmid">27281575</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyland</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Microbe-host interactions: influence of the gut microbiota on the enteric nervous system</article-title>
<source/>Dev Biol
          <year>2016</year>
<volume>417</volume>
<fpage>182</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">27343895</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>AI</given-names>
</name>
</person-group>
<article-title>Structure and regulation of intestinal epithelial tight junctions: current concepts and unanswered questions</article-title>
<source/>Adv Exp Med Biol
          <year>2012</year>
<volume>763</volume>
<fpage>132</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="pmid">23397622</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Transcutaneous vagus nerve stimulation: a promising method for treatment of autism spectrum disorders</article-title>
<source/>Front Neurosci
          <year>2017</year>
<volume>10</volume>
<fpage>609</fpage>
<pub-id pub-id-type="pmid">28163670</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>DW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<fpage>10</fpage>
<pub-id pub-id-type="pmid">28122648</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>CJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function</article-title>
<source/>Cell Host Microbe
          <year>2015</year>
<volume>17</volume>
<fpage>662</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">25865369</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat</article-title>
<source/>J Psychiatr Res
          <year>2016</year>
<volume>82</volume>
<fpage>109</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="pmid">27491067</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosikowska</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Biernasiuk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Korona-Glowniak</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kiciak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tomasiewicz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Malm</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The association of chronic hepatitis C with respiratory microbiota disturbance on the basis of decreased <italic>Haemophilus</italic> spp. colonization</article-title>
<source/>Med Sci Monit
          <year>2016</year>
<volume>22</volume>
<fpage>625</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="pmid">26912163</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kutchko</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Siltberg-Liberles</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Metazoan innovation: from aromatic amino acids to extracellular signaling</article-title>
<source/>Amino Acids
          <year>2013</year>
<volume>45</volume>
<fpage>359</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="pmid">23690137</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamberts</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Hildebrandt</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Brundin</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Spreading of alpha-synuclein in the face of axonal transport deficits in Parkinson’s disease: a speculative synthesis</article-title>
<source/>Neurobiol Dis
          <year>2015</year>
<volume>77</volume>
<fpage>276</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="pmid">25046996</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Beatty</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Genetic analysis of a bacterial genetic exchange element: the gene transfer agent of <italic>Rhodobacter capsulatus</italic></article-title>
<source/>Proc Natl Acad Sci USA
          <year>2000</year>
<volume>97</volume>
<fpage>859</fpage>
<lpage>864</lpage>
<pub-id pub-id-type="pmid">10639170</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson’s disease</article-title>
<source/>J Neurosci
          <year>2001</year>
<volume>21</volume>
<fpage>8447</fpage>
<lpage>8455</lpage>
<pub-id pub-id-type="pmid">11606633</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebouvier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chaumette</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Paillusson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duyckaerts</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bruley des Varannes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Neunlist</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Derkinderen</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The second brain and Parkinson’s disease</article-title>
<source/>Eur J Neurosci
          <year>2009</year>
<volume>30</volume>
<fpage>735</fpage>
<lpage>741</lpage>
<pub-id pub-id-type="pmid">19712093</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Indole production by the tryptophanase TnaA in <italic>Escherichia coli</italic> is determined by the amount of exogenous tryptophan</article-title>
<source/>Microbiology
          <year>2013</year>
<volume>159</volume>
<fpage>402</fpage>
<lpage>410</lpage>
<pub-id pub-id-type="pmid">23397453</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>YC</given-names>
</name>
</person-group>
<article-title>Alteration of behavior and monoamine levels attributable to <italic>Lactobacillus plantarum</italic> PS128 in germ-free mice</article-title>
<source/>Behav Brain Res
          <year>2016</year>
<volume>298</volume>
<fpage>202</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">26522841</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hubain</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Loas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jurysta</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Treatment resistant depression: actuality and perspectives in 2017</article-title>
<source/>Rev Med Brux
          <year>2017</year>
<volume>38</volume>
<fpage>16</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">28525197</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macedo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Filho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Soares de Sousa</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Quevedo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barichello</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Junior</surname>
<given-names>HVN</given-names>
</name>
<name>
<surname>Freitas de Lucena</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness</article-title>
<source/>J Affect Disord
          <year>2017</year>
<volume>208</volume>
<fpage>22</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">27744123</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Main</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Minter</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Microbial immuno-communication in neurodegenerative diseases</article-title>
<source/>Front Neurosci
          <year>2017</year>
<volume>11</volume>
<fpage>151</fpage>
<pub-id pub-id-type="pmid">28386215</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malkki</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Parkinson disease: could gut microbiota influence severity of Parkinson disease?</article-title>
<source/>Nat Rev Neurol
          <year>2017</year>
<volume>13</volume>
<fpage>66</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">27982042</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manoharan</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homeostatic PPARα signaling limits inflammatory responses to commensal microbiota in the intestine</article-title>
<source/>J Immunol
          <year>2016</year>
<volume>196</volume>
<fpage>4739</fpage>
<lpage>4749</lpage>
<pub-id pub-id-type="pmid">27183583</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariani</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism</article-title>
<source/>Spectr Disord Cell
          <year>2015</year>
<volume>162</volume>
<fpage>375</fpage>
<lpage>390</lpage>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Jessup</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>The diverse metabolic roles of peripheral serotonin</article-title>
<source/>Endocrinology
          <year>2017</year>
<volume>158</volume>
<fpage>1049</fpage>
<lpage>1063</lpage>
<pub-id pub-id-type="pmid">28323941</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mawe</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2013</year>
<volume>10</volume>
<fpage>473</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="pmid">23797870</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McWilliams</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Muqit</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>PINK1 and Parkin: emerging themes in mitochondrial homeostasis</article-title>
<source/>Curr Opin Cell Biol
          <year>2017</year>
<volume>45</volume>
<fpage>83</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">28437683</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertsalmi</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Aho</surname>
<given-names>VTE</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>PAB</given-names>
</name>
<name>
<surname>Paulin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pekkonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Auvinen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>More than constipation—bowel symptoms in Parkinson’s disease and their connection to gut microbiota</article-title>
<source/>Eur J Neurol
          <year>2017</year>
<volume>24</volume>
<fpage>1375</fpage>
<lpage>1383</lpage>
<pub-id pub-id-type="pmid">28891262</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mittal</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurotransmitters: the critical modulators regulating gut-brain axis</article-title>
<source/>J Cell Physiol
          <year>2017</year>
<volume>232</volume>
<fpage>2359</fpage>
<lpage>2372</lpage>
<pub-id pub-id-type="pmid">27512962</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moonen</surname>
<given-names>AJH</given-names>
</name>
<name>
<surname>Wijers</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dujardin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Leentjens</surname>
<given-names>AFG</given-names>
</name>
</person-group>
<article-title>Neurobiological correlates of emotional processing in Parkinson’s disease: a systematic review of experimental studies</article-title>
<source/>J Psychosom Res
          <year>2017</year>
<volume>100</volume>
<fpage>65</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">28789795</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonaz</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Brain-gut-microbiota axis in Parkinson’s disease</article-title>
<source/>World J Gastroenterol
          <year>2015</year>
<volume>21</volume>
<fpage>10609</fpage>
<lpage>10620</lpage>
<pub-id pub-id-type="pmid">26457021</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noble</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Kanoski</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment</article-title>
<source/>Front Behav Neurosci
          <year>2017</year>
<volume>11</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">28194099</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pachnis</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>The effect of microbiota and the immune system on the development and organization of the enteric nervous system</article-title>
<source/>Gastroenterology
          <year>2016</year>
<volume>151</volume>
<fpage>836</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="pmid">27521479</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Leary</surname>
<given-names>OF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2018</year>
<volume>28</volume>
<fpage>307</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="pmid">29426666</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Mahony</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Borre</surname>
<given-names>YE</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Serotonin, tryptophan metabolism and the brain-gut-microbiome axis</article-title>
<source/>Behav Brain Res
          <year>2015</year>
<volume>277</volume>
<fpage>32</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">25078296</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omenetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pizarro</surname>
<given-names>TT</given-names>
</name>
</person-group>
<article-title>The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome</article-title>
<source/>Front Immunol
          <year>2015</year>
<volume>6</volume>
<fpage>639</fpage>
<pub-id pub-id-type="pmid">26734006</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Özoğul</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Production of biogenic amines by <italic>Morganella morganii, Klebsiella pneumoniae</italic> and <italic>Hafnia alvei</italic> using a rapid HPLC method</article-title>
<source/>Eur Food Res Technol
          <year>2004</year>
<volume>219</volume>
<fpage>465</fpage>
<lpage>469</lpage>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persico</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Napolioni</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Urinary p-cresol in autism spectrum disorder</article-title>
<source/>Neurotoxicol Teratol
          <year>2013</year>
<volume>36</volume>
<fpage>82</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">22975621</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petra</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Panagiotidou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hatziagelaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation</article-title>
<source/>Clin Ther
          <year>2015</year>
<volume>37</volume>
<fpage>984</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="pmid">26046241</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dittel</surname>
<given-names>BN</given-names>
</name>
</person-group>
<article-title>Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis</article-title>
<source/>Immunology
          <year>2015</year>
<volume>146</volume>
<fpage>359</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="pmid">26211540</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reigstad</surname>
<given-names>CS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells</article-title>
<source/>FASEB J
          <year>2015</year>
<volume>29</volume>
<fpage>1395</fpage>
<lpage>1403</lpage>
<pub-id pub-id-type="pmid">25550456</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rietdijk</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Perez-Pardo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Garssen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Wezel</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Kraneveld</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>Exploring Braak’s hypothesis of Parkinson’s disease</article-title>
<source/>Front Neurol
          <year>2017</year>
<volume>8</volume>
<fpage>37</fpage>
<pub-id pub-id-type="pmid">28243222</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ochoa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sternberg</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Loer</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>A comparison of experience-dependent locomotory behaviors and biogenic amine neurons in nematode relatives of <italic>Caenorhabditis elegans</italic></article-title>
<source/>BMC Neurosci
          <year>2010</year>
<volume>11</volume>
<fpage>22</fpage>
<pub-id pub-id-type="pmid">20167133</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rolig</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The enteric nervous system promotes intestinal health by constraining microbiota composition</article-title>
<source/>PLoS Biol
          <year>2017</year>
<volume>15</volume>
<fpage>e2000689</fpage>
<pub-id pub-id-type="pmid">28207737</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Roshchina</surname>
<given-names>VV</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Lyte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Freestone</surname>
<given-names>PPE</given-names>
</name>
</person-group>
<article-title>Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells</article-title>
<source/>Microbial endocrinology: interkingdom signaling in infectious disease and health
          <year>2010</year>
<publisher-loc>New York</publisher-loc>
<publisher-name>Springer</publisher-name>
<fpage>17</fpage>
<lpage>52</lpage>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salloum</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Gott</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Conway</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Sustained remission in patients with treatment-resistant depression receiving vagal nerve stimulation: a case series</article-title>
<source/>Brain Stimul
          <year>2017</year>
<volume>10</volume>
<fpage>997</fpage>
<lpage>1000</lpage>
<pub-id pub-id-type="pmid">28645560</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>
<source/>Mov Disord
          <year>2015</year>
<volume>30</volume>
<fpage>350</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">25476529</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>W</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Greenblatt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brogan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Clostridia bacteria in the gastrointestinal tract as a major cause of depression and other neuropsychiatric disorders</article-title>
<source/>Integrative psychiatry for depression: redefining models for assessment, treatment, and prevention of mood disorders
          <year>2016</year>
<publisher-loc>New York</publisher-loc>
<publisher-name>Taylor and Francis</publisher-name>
<fpage>31</fpage>
<lpage>48</lpage>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherwin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rea</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>A gut (microbiome) feeling about the brain</article-title>
<source/>Curr Opin Gastroenterol
          <year>2016</year>
<volume>32</volume>
<fpage>96</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">26760398</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shishov</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Kirovskaia</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Kudrin</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Oleskin</surname>
<given-names>AV</given-names>
</name>
</person-group>
<article-title>[Amine neuromediators, their precursors, and oxidation products in the culture of <italic>Escherichia coli</italic> K-12]</article-title>
<source/>Prikl Biokhim Mikrobiol
          <year>2009</year>
<volume>45</volume>
<fpage>550</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="pmid">19845286</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Biophysical approaches to the study of LeuT, a prokaryotic homolog of neurotransmitter sodium symporters</article-title>
<source/>Methods Enzymol
          <year>2015</year>
<volume>557</volume>
<fpage>167</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">25950965</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Go</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Redox dynamics of manganese as a mitochondrial life-death switch</article-title>
<source/>Biochem Biophys Res Commun
          <year>2017</year>
<volume>482</volume>
<fpage>388</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="pmid">28212723</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snyder</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ptacek</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Mitochondria, microbiome and their potential psychiatric modulation</article-title>
<source/>Autism Open Access
          <year>2015</year>
<volume>5</volume>
<fpage>144</fpage>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonetti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ottaviani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rodriquez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stefano</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Scharrer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Microglia in invertebrate ganglia</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1994</year>
<volume>91</volume>
<fpage>9180</fpage>
<lpage>9184</lpage>
<pub-id pub-id-type="pmid">8090788</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Finegold</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Real-time PCR quantitation of clostridia in feces of autistic children</article-title>
<source/>Appl Environ Microbiol
          <year>2004</year>
<volume>70</volume>
<fpage>6459</fpage>
<lpage>6465</lpage>
<pub-id pub-id-type="pmid">15528506</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Conformational matching: a possible evolutionary force in the evolvement of signal systems</article-title>
<source/>CRC Handbook of comparative opioid and related neuropeptide mechanisms
          <year>1986</year>
<publisher-loc>Boca Raton</publisher-loc>
<publisher-name>CRC Press Inc.</publisher-name>
<fpage>271</fpage>
<lpage>277</lpage>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (review)</article-title>
<source/>Int J Mol Med
          <year>2007</year>
<volume>20</volume>
<fpage>837</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="pmid">17982691</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Dopamine, morphine, and nitric oxide: an evolutionary signaling triad CNS</article-title>
<source/>Neurosci Ther
          <year>2010</year>
<volume>16</volume>
<fpage>e124</fpage>
<lpage>e137</lpage>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Psychiatric disorders involving mitochondrial processes</article-title>
<source/>Psychol Obs
          <year>2015</year>
<volume>1</volume>
<fpage>1</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Evolutionary perspective on microglial/neuronal coupling with special relevance to psychiatric illnesses</article-title>
<source/>J Psychiatr
          <year>2015</year>
<volume>18</volume>
<fpage>329</fpage>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Mitochondrial DNA heteroplasmy in human health and disease</article-title>
<source/>Biomed Rep
          <year>2016</year>
<volume>4</volume>
<fpage>259</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="pmid">26998260</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Catapane</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Aiello</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Dopaminergic agents: influence on serotonin in the molluscan nervous system</article-title>
<source/>Science
          <year>1976</year>
<volume>194</volume>
<fpage>539</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="pmid">973139</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Bilfinger</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Fricchione</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>The immune neuro-link and the macrophage: <italic>Postcardiotomy delirium</italic>. HIV-associated dementia psychiatry</article-title>
<source/>Prog Neurobiol
          <year>1994</year>
<volume>42</volume>
<fpage>475</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="pmid">8090931</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Antibiotics may trigger mitochondrial dysfunction inducing psychiatric disorders</article-title>
<source/>Med Sci Monit
          <year>2017</year>
<volume>23</volume>
<fpage>101</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="pmid">28063266</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kallarackal</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kvarta</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Van Dyke</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>LeGates</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>An excitatory synapse hypothesis of depression</article-title>
<source/>Trends Neurosci
          <year>2015</year>
<volume>38</volume>
<fpage>279</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="pmid">25887240</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tobe</surname>
<given-names>EH</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction, oxidative stress, and major depressive disorder</article-title>
<source/>Neuropsychiatr Dis Treat
          <year>2013</year>
<volume>9</volume>
<fpage>567</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="pmid">23650447</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Appel-Cresswell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The gut microbiome in human neurological disease: a review</article-title>
<source/>Ann Neurol
          <year>2017</year>
<volume>81</volume>
<fpage>369</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="pmid">28220542</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tulstrup</surname>
<given-names>MV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<fpage>e0144854</fpage>
<pub-id pub-id-type="pmid">26691591</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unger</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls</article-title>
<source/>Parkinsonism Relat Disord
          <year>2016</year>
<volume>32</volume>
<fpage>66</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">27591074</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verheijden</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Schepper</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boeckxstaens</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>Neuron-macrophage crosstalk in the intestine: a “microglia” perspective</article-title>
<source/>Front Cell Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>403</fpage>
<pub-id pub-id-type="pmid">26528133</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermeiren</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>De Deyn</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Targeting the norepinephrinergic system in Parkinson’s disease and related disorders: the locus coeruleus story</article-title>
<source/>Neurochem Int
          <year>2017</year>
<volume>102</volume>
<fpage>22</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">27899296</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villaran</surname>
<given-names>RF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson’s disease</article-title>
<source/>J Neurochem
          <year>2010</year>
<volume>114</volume>
<fpage>1687</fpage>
<lpage>1700</lpage>
<pub-id pub-id-type="pmid">20584104</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Milev</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The effects of probiotics on depressive symptoms in humans: a systematic review</article-title>
<source/>Ann Gen Psychiatr
          <year>2017</year>
<volume>16</volume>
<fpage>14</fpage>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Milev</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Erratum to: the effects of probiotics on depressive symptoms in humans: a systematic review</article-title>
<source/>Ann Gen Psychiatr
          <year>2017</year>
<volume>16</volume>
<fpage>18</fpage>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wells</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homeostasis of the gut barrier and potential biomarkers</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2017</year>
<volume>312</volume>
<fpage>G171</fpage>
<lpage>G193</lpage>
<pub-id pub-id-type="pmid">27908847</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winklhofer</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction in Parkinson’s disease</article-title>
<source/>Biochim Biophys Acta
          <year>2010</year>
<volume>1802</volume>
<fpage>29</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="pmid">19733240</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>
<source/>Science
          <year>2011</year>
<volume>334</volume>
<fpage>105</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="pmid">21885731</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Bushmanc</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Diet, the human gut microbiota and IBD</article-title>
<source/>Anaerobe
          <year>2013</year>
<volume>24</volume>
<fpage>117</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">23548695</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yakunina</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>Optimization of transcutaneous vagus nerve stimulation using functional MRI</article-title>
<source/>Neuromodulation
          <year>2017</year>
<volume>20</volume>
<fpage>290</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">27898202</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashita</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Kawate</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Crystal structure of a bacterial homologue of Na+/Cl− dependent neurotransmitter transporters</article-title>
<source/>Nature
          <year>2005</year>
<volume>437</volume>
<fpage>215</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">16041361</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yano</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>264</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="pmid">25860609</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>The enteric network: interactions between the immune and nervous systems of the Gut</article-title>
<source/>Immunity
          <year>2017</year>
<volume>46</volume>
<fpage>910</fpage>
<lpage>926</lpage>
<pub-id pub-id-type="pmid">28636959</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism</article-title>
<source/>Mol Psychiatr
          <year>2016</year>
<volume>21</volume>
<fpage>786</fpage>
<lpage>796</lpage>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Psychobiotics and the gut-brain axis: in the pursuit of happiness</article-title>
<source/>Neuropsychiatr Dis Treat
          <year>2015</year>
<volume>11</volume>
<fpage>715</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="pmid">25834446</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>